References
Andruszko B, Dodds Ashley E. Antifungal Stewardship: an Emerging Practice in Antimicrobial Stewardship. Curr Clin Micro Rpt. 2016;3(3):111–9.
Cortegiani A et al. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev. 2016;1:CD004920.
Murad MH et al. How to read a systematic review and meta-analysis and apply the results to patient care: users’ guides to the medical literature. JAMA. 2014;312(2):171–9.
Ostrosky-Zeichner L et al. MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis. 2014;58(9):1219–26.
Pappas PG et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–e50.
Posteraro B et al. (1,3)-beta-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study. J Antimicrob Chemother. 2016;71(8):2262–9.
Leon C et al. Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009;37(5):1624–33.
Leroy G et al. Evaluation of “Candida score” in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Intensive Care. 2011;1(1):50.
Leon C et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34(3):730–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Andruszko, B., Dodds Ashley, E. Reply to Russotto et al.. Curr Clin Micro Rpt 3, 173–174 (2016). https://doi.org/10.1007/s40588-016-0051-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40588-016-0051-5